Dose-dependent effect of growth hormone on final height in children with short stature without growth hormone deficiency

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 11, 2008, Pages 4342-4350

  Albertsson Wikland, Kerstin ^a,h   Aronson, A Stefan ^b   Gustafsson, Jan ^c   Hagenäs, Lars ^d   Ivarsson, Sten A ^e   Jonsson, Björn ^c   Kriström, Berit ^a,f   Marcus, Claude ^d   Nilsson, Karl Olof ^e   Ritzén, E Martin ^d   Tuvemo, Torsten ^c   Westphal, Otto ^a   Åman, Jan ^g  

^a SAHLGRENSKA ACADEMY AT UNIVERSITY OF GOTHENBURG   (Sweden)

^b HALMSTAD HOSPITAL   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

^d KAROLINSKA INSTITUTE   (Sweden)

^e LUND UNIVERSITY HOSPITAL   (Sweden)

^f UMEÅ UNIVERSITY   (Sweden)

^g ÖREBRO UNIVERSITY   (Sweden)

^h QUEEN SILVIA CHILDREN'S HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN GROWTH HORMONE;

ADOLESCENT; ARTICLE; BODY HEIGHT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; GROWTH HORMONE DEFICIENCY; HUMAN; HYPERGLYCEMIA; HYPOPHYSIS DISEASE; INSULIN BLOOD LEVEL; IRRITABILITY; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; MULTICENTER STUDY; MULTIPLE PERSONALITY; OUTCOME ASSESSMENT; PITUITARY CYST; PREPUBERTY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SHORT STATURE; SIDE EFFECT; SWEDEN; THYROID DISEASE;

EID: 57349180874     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-0707     Document Type: Article

References (38)

1. Raben MS 1958 Treatment of a pituitary dwarf with human growth hormone. J Clin Endocrinol Metab 18:901-903
2. Lenko HL, Leisti S, Perheentupa J 1982 The efficacy of growth hormone in different types of growth failure. An analysis of 101 cases. Eur J Pediatr 138: 241-249
3. Tanner JM, Whitehouse RH, Hughes PC, Vince FP 1971 Effect of human growth hormone treatment for 1 to 7 years on growth of 100 children, with growth hormone deficiency, low birthweight, inherited smallness, Turner's syndrome, and other complaints. Arch Dis Child 46:745-782
4. Albertsson-Wikland K 1987 Clinical trial with authentic recombinant somatropin in Sweden and Finland. Acta Paediatr Scand Suppl 331:28-34
5. Attie K, Bengtsson B-Å, Blethen S, Blum W, Cameron F, Carel J, Carlsson L, Chipman J, Sandahl Christiansen J, Clayton P, Clemmons D, Cohen P, Drop S, Fujieda K, Ghingo E, Hintz R, Ho K, Ilondo M, Jasper H, Jesussek B, Kappelgaard A, Laron Z, Lippe B, Malozowski S, Mullis P, de Muinck-Keizer- Schrama S, Nishi Y, Parks J, Phelps C, Ranke M, Robinson I, Rosenfeld R, Rose S, Saenger P, Saggese G, Savage M, Shalet S, Sizonenko P, Strasburger C, Tachibana K, Tanaka T, Thorner M, Albertsson-Wikland K, Zadik Z 2000 Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. J Clin Endocrinol Metab 85:3990-3993
6. Jansson C, Boguszewski C, Rosberg S, Carlsson L, Albertsson-Wikland K 1997 Growth hormone (GH) assays: influence of standard preparations, GH isoforms, assay characteristics, and GH-binding protein. Clin Chem 43:950-956
7. Kristrom B, Karlberg J, Albertsson-Wikland K 1995 Prediction of the growth response of short prepubertal children treated with growth hormone. Swedish Paediatric Study Group for GH treatment. Acta Paediatr 84:51-57
8. Rosenfeld RG, Albertsson-Wikland K, Cassorla F, Frasier SD, Hasegawa Y, Hintz RL, Lafranchi S, Lippe B, Loriaux L, Melmed S, Preece MA, Ranke MB, Reiter EO, Rogol AD, Underwood LE, Werther GA 1995 Diagnostic controversy: the diagnosis of childhood growth hormone deficiency revisited. J Clin Endocrinol Metab 80:1532-1540
9. Maneatis T, Baptista J, Connelly K, Blethen S 2000 Growth hormone safety update from the National Cooperative Growth Study. J Pediatr Endocrinol Metab 13(Suppl 2):1035-1044
10. Wilton P 2001 Safety in growth hormone replacement therapy: a matter of varied responsiveness? Horm Res 55(Suppl 2):61-64
11. Albertsson-Wikland K 1988 Growth hormone treatment in short children - short-term and long-term effects on growth. Acta Paediatr Scand Suppl 343: 77-84
12. Ritzen M, Albertsson-Wikland K 1989 GH of short stature. State-of-the-art 1989. Acta Paediatr Scand Suppl 362:1-89
13. Underwood LE 1984 Report of the conference on uses and possible abuses of biosynthetic human growth hormone. N Engl J Med 311:606-608
14. Leschek EW, Rose SR, Yanovski JA, Troendle JF, Quigley CA, Chipman JJ, Crowe BJ, Ross JL, Cassorla FG, Blum WF, Cutler Jr GB, Baron J 2004 Effect of growth hormone treatment on adult height in peripubertal children with idiopathic short stature: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab 89:3140-3148
15. Hintz RL, Attie KM, Baptista J, Roche A 1999 Effect of growth hormone treatment on adult height of children with idiopathic short stature. Genentech Collaborative Group. N Engl J Med 340:502-507
16. Wit JM, Rekers-Mombarg LT, Cutler GB, Crowe B, Beck TJ, Roberts K, Gill A, Chaussain JL, Frisch H, Yturriaga R, Attanasio AF 2005 Growth hormone (GH) treatment to final height in children with idiopathic short stature: evidence for a dose effect. J Pediatr 146:45-53
17. Albertsson-Wikland K, Luo ZC, Niklasson A, Karlberg J 2002 Swedish population-based longitudinal reference values from birth to 18 years of age for height, weight and head circumference. Acta Paediatr 91:739-754
18. Ranke MB 1996 Towards a consensus on the definition of idiopathic short stature. Horm Res 45(Suppl 2):64-66
19. Wit JM, Clayton PE, Rogol AD, Savage MO, Saenger PH, Cohen P 2008 Idiopathic short stature: definition, epidemiology, and diagnostic evaluation. Growth Horm IGF Res 18:89-110
20. Karlberg J, Albertsson-Wikland K 1995 Growth in full-term small-for-gestational-age infants: from birth to final height. Pediatr Res 38:733-739
21. Niklasson A, Ericson A, Fryer JG, Karlberg J, Lawrence C, Karlberg P 1991 An update of the Swedish reference standards for weight, length and head circumference at birth for given gestational age (1977-1981). Acta Paediatr Scand 80:756-762
22. Albertsson-Wikland K, Rosberg S, Libre E, Lundberg LO, Groth T 1989 Growth hormone secretory rates in children as estimated by deconvolution analysis of 24-h plasma concentration profiles. Am J Physiol 257:E809-E814
23. Löfqvist C, Andersson E, Gelander L, Rosberg S, Blum WF, Albertsson Wikland K 2001 Reference values for IGF-I throughout childhood and adolescence: a model that accounts simultaneously for the effect of gender, age, and puberty. J Clin Endocrinol Metab 86:5870-5876
24. Löfqvist C, Andersson E, Gelander L, Rosberg S, Hulthen L, Blum WF, Albertsson-Wikland K 2005 Reference values for insulin-like growth factor-binding protein-3 (IGFBP-3) and the ratio of insulin-like growth factor-I to IGFBP-3 throughout childhood and adolescence. J Clin Endocrinol Metab 90:1420-1427
25. Karlberg J 1989 On the construction of the infancy-childhood- puberty growth standard. Acta Paediatr Scand Suppl 356:26-37
26. Luo ZC, Albertsson-Wikland K, Karlberg J 1998 Target height as predicted by parental heights in a population-based study. Pediatr Res 44:563-571
27. Karlberg J, Luo ZC, Albertsson-Wikland K 2001 Body mass index reference values (mean and SD) for Swedish children. Acta Paediatr 90:1427-1434
28. Frasier SD, Costin G, Lippe BM, Aceto Jr T, Bunger PF 1981 A dose-response curve for human growth hormone. J Clin Endocrinol Metab 53: 1213-1217
29. Albertsson-Wikland K, Westphal O, Westgren U 1986 Daily subcutaneous administration of human growth hormone in growth hormone deficient children. Acta Paediatr Scand 75:89-97
30. Rose SR, Baron J, Bernstein D, Yanovski J, Troendle JF, Leschek E, Chipman J, Cutler Jr GB 2000 Suppression and recovery of GH secretion after GH injection in non-GH deficient short children. J Pediatr Endocrinol Metab 13: 281-288
31. Albertsson-Wikland K, Rosberg S, Karlberg J, Groth T 1994 Analysis of 24-hour growth hormone profiles in healthy boys and girls of normal stature: relation to puberty. J Clin Endocrinol Metab 78:1195-1201
32. Rosenfeld RG 2005 The molecular basis of idiopathic short stature. Growth Horm IGF Res 15(Suppl A):S3-S5
33. Albertsson Wikland K, Kristrom B, Rosberg S, Svensson B, Nierop AF 2000 Validated multivariate models predicting the growth response to GH treatment in individual short children with a broad range in GH secretion capacities. Pediatr Res 48:475-484
34. Dahlgren J, Kristrom B, Niklasson A, Nierop AF, Rosberg S, Albertsson- Wikland K 2007 Models predicting the growth response to growth hormone treatment in short children independent of GH status, birth size and gestational age. BMC Med Inform Decis Mak 7:40
35. Ranke MB, Lindberg A, Chatelain P, Wilton P, Cutfield W, Albertsson-Wikland K, Price DA 1999 Derivation and validation of a mathematical model for predicting the response to exogenous recombinant human growth hormone (GH) in prepubertal children with idiopathic GH deficiency. KIGS International Board. Kabi Pharmacia International Growth Study. J Clin Endocrinol Metab 84:1174-1183
36. Schonau E, Westermann F, Rauch F, Stabrey A, Wassmer G, Keller E, Bramswig J, Blum WF 2001 A new and accurate prediction model for growth response to growth hormone treatment in children with growth hormone deficiency. Eur J Endocrinol 144:13-20
37. Kristrom B, Dahlgren J, Aronson S, Gustafsson J, Halldin M, Ivarsson S, Nilsson NO, Svensson J, Tuvemo T, Albertsson Wikland K 2006 Individualized growth hormone (GH) dosing brings children closer to their target height after 2 years of treatment - a randomized study including prepubertal IGHD and ISS children. Horm Res 65:P159 (Abstract P101-553)
38. Hochberg Z, Albertsson-Wikland K 2008 Evo-devo of infantile and childhood growth. Pediatr Res 64:2-7